Work

How can we trick the immune system into overcoming the detrimental effects of oncolytic viral therapy to treat glioblastoma?

Year: 2013

Type: article

Abstract: Although China approved the use of the H101 adenovirus for the treatment of various solid cancers in 2005, similar viruses have not obtained clinical approval in the USA [1]. While there are severa...

Source: Expert Review of Neurotherapeutics

DOI: 10.1586/ern.13.25

Authors: Walter H Meisen, Balveen Kaur

Institution: The Ohio State University Wexner Medical Center

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: OV therapy induced changes in tumor secretome and their impact on therapy, Enhancing viral oncolysis with vasculostatin gene delivery, Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas

OpenAlex ID: W1989453926

FWCI: 0.576

Cites: 19

Cited by: 11

Related to: 10